Эгоистичная митохондрия. Как сохранить здоровье и отодвинуть старость

Olsen E. A., Brambrink A. M. Anesthetic neurotoxicity in the newborn and infant. Curr Opin Anaesthesiol. 2013 Oct; 26(5):535–42. Epub 2013 Aug 29. doi:10.1097/01.aco.0000433061.59939.b7.

Reid A. B., et al. Mechanisms of acetaminophen-induced hepatotoxicity: role of oxidative stress and mitochondrial permeability transition in freshly isolated mouse hepatocytes. J Pharmacol Exp Ther. 2005 Feb; 312(2):509–16. doi:10.1124/jpet.104.075945.

Roberton A. M., Ferguson L. R., Cooper G. J. Biochemical evidence that high concentrations of the antidepressant amoxapine may cause inhibition of mitochondrial electron transport. Toxicol Appl Pharmacol. 1988 Mar 30; 93(1):118–26. doi:10.1016/0041-008X(88)90031-2.

Shah N. L., Gordon F. D. N-acetylcysteine for acetaminophen overdose: when enough is enough. Hepatology. 2007 Sep; 46(3):939–41.

Sirvent P., et al. Simvastatin induces impairment in skeletal muscle while heart is protected. Biochem Biophys Res Commun. 2005 Dec 23; 338(3):1426–34. doi:10.1016/j.bbrc.2005.10.108.

Sirvent P., et al. Simvastatin triggers mitochondria-induced Ca2+ signaling alteration in skeletal muscle. Biochem Biophys Res Commun. 2005 Apr 15;329(3):1067–75. doi:10.1016/j.bbrc.2005.02.070.

Souza M. E., et al. Effect of fluoxetine on rat liver mitochondria. Biochem Pharmacol. 1994 Aug 3; 48(3):535–41. doi:10.1016/0006-2952(94)90283-6.

Vaughan R. A., et al. Ubiquinol rescues simvastatin-suppression of mitochondrial content, function and metabolism: implications for statin-induced rhabdomyolysis. Eur J Pharmacol. 2013 Jul 5; 711(1–3):1–9. Epub 2013 Apr 24. doi:10.1016/j.ejphar.2013.04.009.

Velho J. A., et al. Statins induce calcium-dependent mitochondrial permeability transition. Toxicology. 2006 Feb; 219(1–3):124–32.

Wang M. Y., Sadun A. A. Drug-related mitochondrial optic neuropathies. J Neuroophthalmol. 2013 Jun;33(2):172–8. doi:10.1097/ WNO.0b013e3182901969.

Westwood F. R., et al. Statin-induced muscle necrosis in the rat: distribution, development, and fibre selectivity. Toxicol Pathol. 2005; 33(2):246–57. doi:10.1080/01926230590908213.

Xia Z., et al. Changes in the generation of reactive oxygen species and in mitochondrial membrane potential during apoptosis induced by the antidepressants imipramine, clomipramine, and citalopram and the effects on these changes by Bcl-2 and BclX(L). Biochem Pharmacol. 1999 May 15; 57(10):1199–208.

Xue S. Y., et al. Nucleoside reverse transcriptase inhibitors induce a mitophagy-associated endothelial cytotoxicity that is reversed by coenzyme Q10 cotreatment. Toxicol Sci. 2013 Aug;134(2):323–34. Epub 2013 May 2. doi:10.1093/toxsci/kft105.

Yousif W. Microscopic studies on the effect of alprazolam (Xanax) on the liver of mice. Pak J Biol Sci. 2002; 5(11):1220–5. doi:10.3923/ pjbs.2002.1220.1225.

Zhao C., Shichi H. Prevention of acetaminophen-induced cataract by a combination of diallyl disulfide and N-acetylcysteine. J Ocul Pharmacol Ther. 1998 Aug; 14(4):345–55. doi:10.1089 /jop.1998.14.345.

Митохондриальный синдром

Bainbridge, L. Understanding and coping with mitochondrial disease. Hamilton, ON: Hamilton Health Sciences; 2010.

Bertini E., D’Amico A. Mitochondrial encephalomyopathies and related syndromes [review]. Endocr Dev. 2009; 14:38–52.

Debray F. G., Lambert M., Mitchell G. A. Disorders of mitochondrial function. Curr Opin Pediatr. 2008 Aug; 20(4):471–82. doi:10.1097/ MOP.0b013e328306ebb6.

DiMauro S., Schon E. A. Mitochondrial respiratory-chain diseases. N Engl J Med. 2003 Jun; 348(26):2656–68. doi:10.1056/NEJMra022567.

DiMauro S., et al. Diseases of oxidative phosphorylation due to mtDNA mutations. Semin Neurol. 2001 Sep; 21(3):251–60. doi:10.1055/s-2001-17942. Finsterer J. Leigh and Leigh-like syndrome in children and adults. Pediatr Neurol. 2008 Oct; 39(4):223–35. doi:10.1016/j.pediatrneurol.2008.07.013.

Folkers K., Simonsen R. Two successful double-blind trials with coenzyme Q10 (vitamin Q10) on muscular dystrophies and neurogenic atrophies. Biochim Biophys Acta. 1995 May 24; 1271(1):281–6.

Goldstein A. C., Bhatia P., Vento J. M. Mitochondrial disease in childhood: nuclear encoded. Neuro-therapeutics. 2013 Apr; 10(2):212–26. Epub Mar 21 2013. doi:10.1007/s13311-013-0185-6.

Kisler J. E., Whittaker R. G., McFarland R. Mitochondrial diseases in childhood: a clinical approach to investigation and management. Dev Med Child Neurol. 2010 May; 52(5):422–33. doi:10.1111/j.1469–8749.2009.03605.x.